Week in review: MicroShunt use in kids, global cataract burden, verteporfin and COVID-19
- Posted on: Nov 18 2022
- Leave a response
The PreserFlo MicroShunt is being studied for use in children, the global burden of cataract continues to rise, and verteporfin has potential against the SARS-CoV-2 virus.
Source: AAO
Posted in: Uncategorized
